Zydus Lifesciences has reported its results for the first quarter ended June 30, 2026 (Q1FY27).
The company has reported an 11.72% decline in its net profit at Rs 339.60 crore for the quarter ended June 30, 2026, as compared to Rs 384.70 crore for the same quarter in the previous year. However, total income increased by 9.12% to Rs 2,995.90 crore for Q1FY27 as compared to Rs 2,745.40 crore for the corresponding quarter of the previous year.
On a consolidated basis, the company has reported a 35.93% decline in its net profit at Rs 939.80 crore for Q1FY27, as compared to Rs 1,466.80 crore for the same quarter in the previous year. However, total income increased by 20.72% to Rs 8,123.10 crore for Q1FY27 as compared to Rs 6,728.60 crore for the corresponding quarter of the previous year.
